2.61
2.61 (0%)
As of Apr 17, 2025
Maxcyte, Inc. [MXCT]
Source:
Company Overview
Maxcyte, Inc is a leading commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics including cell and gene therapies and to support innovative cell-based research and development.
| Country | United States |
| Headquarters | rockville, maryland |
| Phone Number | (301) 944-1700 |
| Industry | services |
| CEO | Maher Masoud |
| Website | www.maxcyte.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $38.6 |
| Operating Profit | $-51.2 |
| Net Income | $-41.1 |
| Net Cash | $-18.6 |
Profit Ratios
| Gross Margin | $31.5 |
| Operating Margin | -132.5 |
| Profit as % of Revenues | -76.8% |
| Profit as % of Assets | -16.2% |
| Profit as % of Stockholder Equity | -19.9% |
Management Effectiveness
| Return on Equity | -19.9% |
| Return on Assets | -17.1% |
| Turnover Ratio | 15.2% |
| EBITA | $-47.1 |
Balance Sheet and Cash Flow Measures
| Total Assets | $239.5 |
| Total Liabilities | $33.2 |
| Operating Cash Flow | $-27.6 |
| Investing Cash Flow | $6.9 |
| Financing Cash Flow | $2.1 |
